Spots Global Cancer Trial Database for bbi608
Every month we try and update this database with for bbi608 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer | NCT02178956 | Gastric Cancer Gastroesophagea... | BBI608 Paclitaxel Placebo | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Adult Patients With Advanced Malignancies | NCT01775423 | Cancer, Advance... | BBI608 | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies | NCT02352558 | Hematologic Mal... | BBI608 Dexamethasone Bortezomib Imatinib Ibrutinib | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer | NCT01776307 | Colorectal Canc... | BBI608 Panitumumab Capecitabine Cetuximab | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer | NCT02641873 | Metastatic Colo... | BBI608 5-FU Irinotecan Levofolinate Bevacizumab | 20 Years - | Sumitomo Pharma Co., Ltd. | |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | NCT02024607 | Advanced Gastro... | BBI608 Fluorouracil Oxaliplatin Leucovorin Irinotecan Bevacizumab Capecitabine Regorafenib | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma | NCT02347917 | Malignant Pleur... Non-Small Cell ... | BBI608 Pemetrexed Cisplatin | 20 Years - | Sumitomo Pharma Co., Ltd. | |
| A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers | NCT02467361 | Cancer | BBI608 Ipilimumab Nivolumab Pembrolizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma | NCT02315534 | Glioblastoma | BBI608 Temozolomide | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors | NCT02432326 | Cancer Advanced Solid ... | BBI608 BBI503 | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | NCT02231723 | Metastatic Panc... | BBI608 Nab-paclitaxel Gemcitabine Oxaliplatin Leucovorin Irinotecan Fluorouracil MM-398 | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies | NCT01325441 | Cancer | BBI608 Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies | NCT02352558 | Hematologic Mal... | BBI608 Dexamethasone Bortezomib Imatinib Ibrutinib | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies | NCT01325441 | Cancer | BBI608 Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
